Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 532594, 10 pages
http://dx.doi.org/10.1155/2014/532594
Research Article

Animal Model of Acid-Reflux Esophagitis: Pathogenic Roles of Acid/Pepsin, Prostaglandins, and Amino Acids

1Division of Pathological Sciences, Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Misasagi, Yamashina, Kyoto 607-8414, Japan
2General Incorporated Association, Kyoto Research Center for Gastrointestinal Diseases, Karasuma-Oike 671, Kyoto 604-8106, Japan

Received 5 August 2013; Revised 13 November 2013; Accepted 20 December 2013; Published 2 February 2014

Academic Editor: Peter Malfertheiner

Copyright © 2014 Koji Takeuchi and Kenji Nagahama. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. R. DeMeester, J. A. Wernly, and G. H. Bryant, “Clinical and in vitro analysis of determinants of gastroesophageal competence. A study of the principles of antireflux surgery,” American Journal of Surgery, vol. 137, no. 1, pp. 39–46, 1979. View at Google Scholar · View at Scopus
  2. R. H. Hunt, “Importance of pH control in the management of GERD,” Archives of Internal Medicine, vol. 159, no. 7, pp. 649–657, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. S. G. M. Meuwissen and E. C. Klinkenberg-Knol, “Treatment of reflux oesophagitis with H2-receptor antagonists,” Scandinavian Journal of Gastroenterology, Supplement, vol. 23, supplement 146, pp. 201–213, 1988. View at Google Scholar · View at Scopus
  4. E. C. Klinkenberg-Knol, J. B. M. J. Jansen, C. B. H. W. Lamers, F. Nelis, P. Snel, and S. G. M. Meuwissen, “Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists,” Scandinavian Journal of Gastroenterology, Supplement, vol. 24, supplement 166, pp. 88–93, 1989. View at Google Scholar · View at Scopus
  5. N. Inatomi, H. Nagaya, K. Takami, A. Shino, and H. Satoh, “Effects of a proton pump inhibitor, AG-1749 (lansoprazole) on reflux esophagitis and experimental ulcers in rats,” Japanese Journal of Pharmacology, vol. 55, no. 4, pp. 437–451, 1991. View at Google Scholar · View at Scopus
  6. B. I. Hirschowitz, “Pepsin and the esophagus,” Yale Journal of Biology and Medicine, vol. 72, no. 2-3, pp. 133–143, 1999. View at Google Scholar · View at Scopus
  7. A. I. Lanas, J. M. Blas, J. Ortego, J. Soria, and R. Sáinz, “Adaptation of esophageal mucosa to acid- and pepsin-induced damage: role of nitric oxide and epidermal growth factor,” Digestive Diseases and Sciences, vol. 42, no. 5, pp. 1003–1012, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. H. I. Goldberg, W. J. Dodds, S. Gee, C. Montgomery, and F. F. Zboralske, “Role of acid and pepsin in acute experimental esophagitis,” Gastroenterology, vol. 56, no. 2, pp. 223–230, 1969. View at Google Scholar · View at Scopus
  9. F. L. Lanza, “Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents,” American Journal of Medicine, vol. 77, no. 1 A, pp. 19–24, 1984. View at Google Scholar · View at Scopus
  10. S. Levi, R. A. Goodlad, C. Y. Lee et al., “Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing,” The Lancet, vol. 336, no. 8719, pp. 840–843, 1990. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Gretzer, N. Maricic, M. Respondek, R. Schuligoi, and B. M. Peskar, “Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge,” British Journal of Pharmacology, vol. 132, no. 7, pp. 1565–1573, 2001. View at Google Scholar · View at Scopus
  12. J. L. Wallace, W. McKnight, B. K. Reuter, and N. Vergnolle, “NSAID-Induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2,” Gastroenterology, vol. 119, no. 3, pp. 706–714, 2000. View at Google Scholar · View at Scopus
  13. A. Tanaka, S. Hase, T. Miyazawa, and K. Takeuchi, “Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage,” Journal of Pharmacology and Experimental Therapeutics, vol. 300, no. 3, pp. 754–761, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Nagahama, M. Yamato, S. Kato, and K. Takeuchi, “Protective effect of lafutidine, a novel H2-receptor antagonist, on reflux esophagitis in rats through capsaicin-sensitive afferent neurons,” Journal of Pharmacological Sciences, vol. 93, no. 1, pp. 55–61, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Nagahama, M. Yamato, H. Nishio, and K. Takeuchi, “Essential role of pepsin in pathogenesis of acid reflux esophagitis in rats,” Digestive Diseases and Sciences, vol. 51, no. 2, pp. 303–309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Yamato, K. Nagahama, T. Kotani, S. Kato, and K. Takeuchi, “Biphasic effect of prostaglandin E2 in a rat model of esophagitis mediated by EPI receptors: relation to pepsin secretion,” Digestion, vol. 72, no. 2-3, pp. 109–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Nagahama, H. Nishio, M. Yamato, and K. Takeuchi, “Orally administered l-arginine and glycine are highly effective against acid reflux esophagitis in rats,” Medical Science Monitor, vol. 18, no. 1, pp. BR9–BR15, 2012. View at Google Scholar · View at Scopus
  18. R. F. Souza, “Molecular mechanisms of acid exposure in Barrett's esophagus,” Inflammopharmacology, vol. 15, no. 3, pp. 95–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Umezawa, T. Aoyagi, H. Morishima, M. Matsuzaki, and M. Hamada, “Pepstatin, a new pepsin inhibitor produced by Actinomycetes,” Journal of Antibiotics, vol. 23, no. 5, pp. 259–262, 1970. View at Google Scholar · View at Scopus
  20. S. Kunimoto, T. Aoyagi, H. Morishima, T. Takeuchi, and H. Umezawa, “Mechanism of inhibition of pepsin by pepstatin,” Journal of Antibiotics, vol. 25, no. 4, pp. 251–255, 1972. View at Google Scholar · View at Scopus
  21. M. Kinoshita, M. Endo, A. Yasoshima et al., “Ecabet sodium, a novel locally-acting anti-ulcer agent, protects the integrity of the gastric mucosal gel layer from pepsin-induced disruption in the rat,” Alimentary Pharmacology and Therapeutics, vol. 13, no. 5, pp. 687–694, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Y. Mabrut, J. M. Collard, and J. Baulieux, “Duodenogastric and gastroesophageal bile reflux,” Journal de Chirurgie, vol. 143, no. 6, pp. 355–365, 2006. View at Google Scholar · View at Scopus
  23. D. Matei, R. Dadu, R. Prundus et al., “Alkaline reflux esophagitis in patients with total gastrectomy and roux en Y esojejunostomy,” Journal of Gastrointestinal and Liver Diseases, vol. 19, no. 3, pp. 247–252, 2010. View at Google Scholar · View at Scopus
  24. R. K. Goyal, “Deleterious effects of prostaglandins on esophageal mucosa,” Gastroenterology, vol. 78, no. 5 I, pp. 1085–1087, 1980. View at Google Scholar · View at Scopus
  25. M. G. Northway, H. I. Libshitz, and B. M. Osborne, “Radiation esophagitis in the opossum: radioprotection with indomethacin,” Gastroenterology, vol. 78, no. 5 I, pp. 883–892, 1980. View at Google Scholar · View at Scopus
  26. H. Araki, K. Yagi, K. Suzuki, O. Furukawa, and K. Takeuchi, “The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach,” Alimentary Pharmacology and Therapeutics, Supplement, vol. 14, supplement 1, pp. 18–25, 2000. View at Google Scholar · View at Scopus
  27. K. Takeuchi, H. Araki, M. Umeda, Y. Komoike, and K. Suzuki, “Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 297, no. 3, pp. 1160–1165, 2001. View at Google Scholar · View at Scopus
  28. K. Takeuchi, Y. Ogawa, S. Kagawa, and H. Ukawa, “Gastric ulcerogenic responses following barrier disruption in knockout mice lacking prostaglandin EP1 receptors,” Alimentary Pharmacology and Therapeutics, Supplement, vol. 16, pp. 74–82, 2002. View at Google Scholar · View at Scopus
  29. K. Takeuchi, S. Kato, and K. Amagase, “Prostaglandin EP receptors involved in modulating gastrointestinal mucosal integrity,” Journal of Pharmacological Sciences, vol. 114, no. 3, pp. 248–261, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Holzer, E. H. Livingston, A. Saria, and P. H. Guth, “Sensory neurons mediate protective vasodilatation in rat gastric mucosa,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 260, no. 3, pp. G363–G370, 1991. View at Google Scholar · View at Scopus
  31. J. Defize and R. H. Hunt, “Effect of hydrochloric acid and prostaglandins on pepsinogen synthesis and secretion in canine gastric chief cell monolayer cultures,” Gut, vol. 30, no. 6, pp. 774–781, 1989. View at Google Scholar · View at Scopus
  32. S. Okabe, K. Takeuchi, and Y. Takata, “Effects of L glutamine on various gastric lesions in rats and guinea pigs,” Digestion, vol. 14, no. 4, pp. 325–331, 1976. View at Google Scholar · View at Scopus
  33. K. Takeuchi, T. Ohuchi, S. Kato, and S. Okabe, “Cytoprotective action of L-Arginine against HCl-induced gastric injury in rats: involvement of nitric oxide?” Japanese Journal of Pharmacology, vol. 61, no. 1, pp. 13–21, 1993. View at Google Scholar · View at Scopus
  34. S. Moncada, R. M. J. Palmer, and E. A. Higgs, “Nitric oxide: physiology, pathophysiology, and pharmacology,” Pharmacological Reviews, vol. 43, no. 2, pp. 109–142, 1991. View at Google Scholar · View at Scopus
  35. L. Laine, K. Takeuchi, and A. Tarnawski, “Gastric mucosal defense and cytoprotection: bench to bedside,” Gastroenterology, vol. 135, no. 1, pp. 41–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. S. K. Ozel, T. E. Dagli, M. Yuksel, G. Kiyan, and E. Kotiloglu, “The roles of free oxygen radicals, nitric oxide, and endothelin in caustic injury of rat esophagus,” Journal of Pediatric Surgery, vol. 39, no. 9, pp. 1381–1385, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Ishiyama, K. Iijima, K. Asanuma et al., “Exogenous luminal nitric oxide exacerbates esophagus tissue damage in a reflux esophagitis model of rats,” Scandinavian Journal of Gastroenterology, vol. 44, no. 5, pp. 527–537, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Ito, S. Okuda, F. Ohkawa et al., “Dual role of nitric oxide in gastric hypersecretion in the distended stomach: Inhibition of acid secretion and stimulation of pepsinongen secretion,” Life Sciences, vol. 83, no. 25-26, pp. 886–892, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. A. De Backer, P. Haentjens, and G. Willems, “Hydrochloric acid. A trigger of cell proliferation in the esophagus of dogs,” Digestive Diseases and Sciences, vol. 30, no. 9, pp. 884–890, 1985. View at Google Scholar · View at Scopus
  40. M. E. Hollwarth, M. Smith, P. R. Kvietys, and D. N. Granger, “Esophageal blood flow in the cat. Normal distribution and effects of acid perfusion,” Gastroenterology, vol. 90, no. 3, pp. 622–628, 1986. View at Google Scholar · View at Scopus
  41. J. Jankowski, G. Coghill, B. Tregaskis, D. Hopwood, and K. G. Wormsley, “Epidermal growth factor in the oesophagus,” Gut, vol. 33, no. 11, pp. 1448–1453, 1992. View at Google Scholar · View at Scopus
  42. R. C. Orlando, “Pathogenesis of gastroesophageal reflux disease,” American Journal of the Medical Sciences, vol. 326, no. 5, pp. 274–278, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. D. O. Castell, J. A. Murray, R. Tutuian, R. C. Orlando, and R. Arnold, “Review article: the pathophysiology of gastro-oesophageal reflux disease—oesophageal manifestations,” Alimentary Pharmacology and Therapeutics, Supplement, vol. 20, supplement 9, pp. 14–25, 2004. View at Google Scholar · View at Scopus
  44. S. J. Konturek, P. C. Konturek, T. Brzozowski, and G. A. Bubenik, “Role of melatonin in upper gastrointestinal tract,” Journal of Physiology and Pharmacology, vol. 58, no. 6, pp. 23–52, 2007. View at Google Scholar · View at Scopus
  45. R. F. Souza, X. Huo, V. Mittal et al., “Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury,” Gastroenterology, vol. 137, no. 5, pp. 1776–1784, 2009. View at Publisher · View at Google Scholar · View at Scopus